Michael König

Mr. Michael KÖNIG is Adviser for Platform Regulation and the Digital Markets Act in the European Commission’s Directorate-General for Communications Networks, Content and Technology (DG CNECT). He was front line negotiator for the Digital Markets Act and will oversee its implementation in DG CNECT.

Before taking up his position in DG CNECT, Mr König was several years Deputy Head of Unit in the European Commission’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (GROW) in the unit responsible for Online services. He was primarily responsible for B2B relations regarding online platforms and negotiated the Regulation on fairness in platform-to-business relations (P2B Regulation).

Mr König joined the European Commission in 2001 in the Directorate-General for Competition. His assignments included a position as advisor to Directorate-General’s top management and a secondment to the OECD, before he joined the Internal Market Directorate-General in 2008. There he held positions in various policy areas including intellectual property, financial services and public procurement.

Before joining the Commission, Mr. König worked for several years in the German Competition Authority and an international law firm.

Mr. König graduated in Law and Economics, and holds a PhD degree in Competition Law.

(Transcript) Protecting Intellectual Property for National Security: A Conversation with Rep. Nathaniel Moran (R-TX)

This transcript is from a CSIS and LeadershIP event hosted on December 3, 2024. Watch the full video here. John J. Hamre: Good afternoon, everybody. Welcome. We’re delighted to have you here. My name is John Hamre. I’m the president at CSIS. And this is going to be one
Read More

Generic Drugs, Property Rights, and the Orange Book

By Chris Borges Intellectual property (IP) rights secured through patents facilitate the introduction of dozens of new brand-name drugs and hundreds of generic drugs annually in the United States. However, proposals advanced by the Biden administration have mistakenly singled out patents as the cause of high drug prices, potentially harming the dense networks
Read More

Intellectual Property Rights and the Future of U.S. Technological Leadership

By Dr. Kirti Gupta This commentary is part of a report from the CSIS Economic Security and Technology Department, titled Staying Ahead in the Global Technology Race. The report features a set of essays outlining key issues on economic security for the next administration, including global technology competition, industrialization
Read More